The size of the European Cell Signaling Market is forecasted to worth USD 1.11 billion by 2026 from USD 0.82 billion in 2021, registering 6.30% CAGR between 2021 to 2026.
Y-O-Y growth in the incidence of chronic diseases and the accessibility of the funds related to cell-based research activities are majorly accelerating this regional market. An increasing number of biopharmaceutical companies and extensive accessibility of developed cell-signaling positively impact the market during the forecast period. The growing importance of cell signaling in biotechnology and medical industries are expected to favor market growth.
Pricing pressure of the cell signaling and the behavioral concerns related to embryonic stem cell signaling research are restraining the market growth in Europe. Moreover, the cost of the equipment and machines needed in researching cell signaling is acting as a potential barrier in the market growth of the region.
This research report on the European Cell Signaling Market has been segmented and sub-segmented into the following categories:
Regional Analysis:
The European market is estimated to hold the second-largest share in the global market between 2020 to 2025. Technological developments in developed economies like Germany are investing heavily in the research and development of cell signaling. Furthermore, favorable government policies are further expected to aid the growth of the market.
Germany is expected to lead the market in the region with a CAGR of 4.4%. The burgeoning involvement of the government for the enhancement of cell-based research in the form of incremental funding is augmenting the market growth during the forecast period in the region.
Key players operating in the Europe Cell Signaling Market profiled in this report are Merck KGaA, Becton, Dickinson and Company, Beckman Coulter, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., PerkinElmer Inc., Promega Corporation, Bio-Techne Corporation, Cell Signaling Technology, Inc., Abcam plc, Miltenyi Biotec, Cell Biolabs Inc., Full Moon BioSystems, Cisbio Bioassays, BioVision, Rockland Immunochemicals Inc., Tonbo Biosciences, StressMarq Biosciences Inc., BPS Bioscience, Abeomics Inc., RayBiotech, MEDICAL & BIOLOGICAL LABORATORIES CO, Sino Biological and Santa Cruz Biotechnology.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Consumables
5.1.2.1 Antibodies
5.1.2.2 Reagents
5.1.2.3 Assay Kits
5.1.2.4 Others
5.1.3 Instruments
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Type
5.2.1 Introduction
5.2.2 Endocrine
5.2.3 Paracrine
5.2.4 Y-o-Y Growth Analysis, By Type
5.2.5 Market Attractiveness Analysis, By Type
5.2.6 Market Share Analysis, By Type
5.3 Application
5.3.1 Introduction
5.3.2 Research
5.3.3 Cancer
5.3.4 Immunology
5.3.5 Y-o-Y Growth Analysis, By Application
5.3.6 Market Attractiveness Analysis, By Application
5.3.7 Market Share Analysis, By Application
5.4 Pathway
5.4.1 Introduction
5.4.2 Akt
5.4.3 AMPK
5.4.4 Hedgehog
5.4.5 Notch
5.4.7 Y-o-Y Growth Analysis, By Pathway
5.4.8 Market Attractiveness Analysis, By Pathway
5.4.9 Market Share Analysis, By Pathway
5.5 Technology
5.5.1 Flow Cytometry
5.5.2 ELISA
5.5.3 Mass Spectrometry
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type
6.1.3.4 By Application
6.1.3.5 By Pathway
6.1.3.6 By Technology
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Type
6.1.4.4 By Application
6.1.4.5 By Pathway
6.1.4.6 By Technology
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Type
6.1.5.4 By Pathway
6.1.5.5 By Indication
6.1.5.6 By Technology
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Merck KGaA
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Becton
8.3 Dickinson and Company
8.4 Beckman Coulter Inc.
8.5 Thermo Fisher Scientific Inc.
8.6 Bio-Rad Laboratories Inc.
8.7 QIAGEN N.V.
8.8 PerkinElmer Inc.
8.9 Promega Corporation
8.10 Bio-Techne Corporation
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
